Correlation Between Creative Medical and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Creative Medical and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Creative Medical and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Creative Medical Technology and ZyVersa Therapeutics, you can compare the effects of market volatilities on Creative Medical and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Creative Medical with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Creative Medical and ZyVersa Therapeutics.
Diversification Opportunities for Creative Medical and ZyVersa Therapeutics
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Creative and ZyVersa is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Creative Medical Technology and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Creative Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Creative Medical Technology are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Creative Medical i.e., Creative Medical and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Creative Medical and ZyVersa Therapeutics
Given the investment horizon of 90 days Creative Medical Technology is expected to generate 0.35 times more return on investment than ZyVersa Therapeutics. However, Creative Medical Technology is 2.86 times less risky than ZyVersa Therapeutics. It trades about -0.42 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 414.00 in Creative Medical Technology on September 1, 2024 and sell it today you would lose (147.00) from holding Creative Medical Technology or give up 35.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Creative Medical Technology vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Creative Medical Tec |
| ZyVersa Therapeutics |
Creative Medical and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Creative Medical and ZyVersa Therapeutics
The main advantage of trading using opposite Creative Medical and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Creative Medical position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Creative Medical vs. Regen BioPharma | Creative Medical vs. Therasense | Creative Medical vs. Enzolytics | Creative Medical vs. Sonnet Biotherapeutics Holdings |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |